Plain-English translation of NCT06069323 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing repetitive transcranial magnetic stimulation (rTMS) — a procedure that uses magnetic pulses to stimulate the brain — as a potential treatment for children with autism spectrum disorder or ADHD. The treatment works by creating magnetic pulses that reach specific areas of the brain involved in these conditions. Researchers believe this approach could help reduce symptoms by rebalancing how the brain communicates.
Currently, there are very limited treatment options for autism's core symptoms, and ADHD medications, while helpful, can cause side effects and may lose effectiveness over time. This trial exists to explore whether this non-invasive brain stimulation technique could offer a safer alternative or additional option for children who aren't helped enough by current treatments.
If you join this study, you will receive 18 magnetic stimulation sessions over 9 weeks, coming twice per week. During each session, a magnetic coil will be placed against your scalp to deliver pulses to your brain — you may feel a tapping sensation or hear clicking sounds, but it is not painful. Some participants will receive the active treatment while others receive a sham (fake) treatment as a control, and neither you nor the researchers will know which group you're in at first.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Italy